Viewing Study NCT00716560


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2025-12-28 @ 12:02 AM
Study NCT ID: NCT00716560
Status: TERMINATED
Last Update Posted: 2025-05-06
First Post: 2008-07-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nausea and Vomiting In Patients Receiving Consecutive Days of Cisplatin
Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University
Organization:

Study Overview

Official Title: Nausea and Vomiting In Patients Receiving Consecutive Days of Cisplatin
Status: TERMINATED
Status Verified Date: 2025-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Administratively terminated.
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to observe the incidence of nausea with systemic chemotherapy that includes consecutive days (more than one day)of cisplatin medication.
Detailed Description: Questionnaires are completed on week of chemotherapy treatment referred to as Dartmouth regimen.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
2004-101 OTHER CCRRC View
0402005015 OTHER_GRANT Merck & Co, Inc. View
JT 1069 OTHER JeffTrial Number View